(Q33659298)

28 July 2017

1 reference

title

Leprosy: pathogenesis updated (English)

1 reference

28 July 2017

0 references

Abulafia J

1

1 reference

PubMed ID

10369539

28 July 2017

Vignale RA

series ordinal

2

1 reference

28 July 2017

1 May 1999

1 reference

International Journal of Dermatology

28 July 2017

1 reference

28 July 2017

38

1 reference

28 July 2017

5

1 reference

28 July 2017

321-334

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

28 July 2017

1 reference

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Immunologic aspects of leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Leprosy: new insight into an ancient disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Immunology of leprosy. A comprehensive survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Th1-Th2 paradigm: insights from leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

St. John Dermatological Society Oration, 1994. Immune responses in leprosy, cytokines and new archetypes for dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Reactions in leprosy. Clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Immunology of reactions in leprosy. Current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Immunohistochemistry in histoid leprosy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Thalidomide in dermatology. New indications for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Autoaggressive hanseniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Treatment of paucibacillary leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

Clofazimine: a review of its medical uses and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00650.X

10.1046/J.1365-4362.1999.00650.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10369539